Quantcast

Latest Pneumococcal polysaccharide vaccine Stories

2010-08-23 11:01:00

NEW YORK, Aug. 23 /PRNewswire-FirstCall/ -- The World Health Organization (WHO) has granted prequalification to Prevenar 13* (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed])for active immunization of infants and children from 6 weeks through five years of age against invasive disease, pneumonia and otitis media caused by the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) contained in the vaccine. WHO prequalification allows for the...

2010-05-05 14:34:01

Kaiser Permanente used electronic health records to study 84,000 men The pneumococcal pneumonia vaccination is not associated with a reduced risk of heart attacks or strokes, according to a Kaiser Permanente study published in the Journal of the American Medical Association that followed 84,170 men aged 45 to 69. The five-year prospective cohort study provides new insights about the association between pneumococcal vaccination and heart attacks and strokes. While previous studies have shown...

2010-03-04 08:27:47

A clinical trial of a vaccine against a major cause of pneumonia and meningitis has shown that it can prevent three out of four cases of re-infection in HIV-infected adults in Africa. The trials, conducted in Malawi and funded by the Wellcome Trust, studied the efficacy of a vaccine against infection with the Streptococcus pneumoniae bacteria. These bacteria are a primary cause of pneumonia and when they invade the blood stream and brain "“ so called invasive pneumococcal disease (IPD)...

2010-02-23 09:10:30

The pneumococcal vaccine for infants and children introduced in 2000 caused a precipitous drop in infections until 2005, when serious illnesses began to rise again, especially infections caused by a strain of the pneumococcal bacteria called 19A, said researchers from Baylor College of Medicine and Texas Children's Hospital in a report in the current issue of the journal Pediatrics. "Of the serotypes (or variants) of Streptococcus pneumoniae (the bacteria that cause pneumococcal disease) now...

2010-01-06 12:24:35

Rituximab treatment reduced patient response to pneumonia vaccine Researchers from Johns Hopkins University determined that immune responses to the tetanus vaccine were not changed when rituximab in combination with methotrexate (MTX) was compared with MTX alone in patients with rheumatoid arthritis (RA). Responses to a pneumococcal vaccination (Pneumovax® pneumonia vaccine), however, were reduced in RA patients with rituximab. Complete findings of this study are published...

73bc5769e0e1d5fcd22a9b48460a79aa1
2009-11-26 07:25:00

On Wednesday U.S. health officials expressed concern over a trend towards increased incidence of bacterial infections in young adults who have contracted the swine flu. Though serious bacterial infections are not uncommon for patients suffering from the flu, the particularly high rate at which it is affecting young people"”typically the most resilient group against such infections"”has given health experts a bit of an alarm.  Dr. Anne Schuchat of the U.S. Centers for Disease...

2009-10-27 06:00:00

SCOTTSDALE, Ariz., Oct. 27 /PRNewswire/ -- Acknowledging the critical role of Centers for Disease Control and Prevention (CDC) guidelines in ensuring the safety and efficacy of H1N1 vaccinations, Carefx Corporation, a leading provider of interoperable workflow solutions to advance the quality and safety of patient care, today announced that Boston Medical Center (BMC) has deployed the Fusionfx Immunization Management portal designed to enter and track H1N1 vaccination administration history...

2009-09-30 14:23:27

Many people who have died of H1N1 influenza in the United States had other bacterial infections that likely contributed to their deaths, health officials say. A report published in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report says those who died of H1N1 influenza had co-infections with a common bacteria such as Streptococcus pneumoniae or pneumococcus. The CDC report included an analysis of specimens taken from 77 fatal cases of H1N1. Bacterial...

2009-08-11 15:30:00

COLLEGEVILLE, Pa., Aug. 11 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced it received notice that the action date for the U.S. Food and Drug Administration's (FDA) review of the Biologics License Application (BLA) for Prevnar 13(TM), (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) has been extended from September 30, 2009, to December 30, 2009. In response to an FDA request, Wyeth submitted additional analytical method...

2009-07-08 07:37:21

Infants who received two or three primary doses of the 7-valent pneumococcal conjugate vaccine (PCV-7) both had a decreased rate of carrying pneumococcal microorganisms that can cause pneumonia and other infections, compared to infants who were not vaccinated, according to a study in the July 8 issue of JAMA.Crowded infant vaccine schedules and less favorable cost-effectiveness calculations have prompted exploration of reduced-dose vaccine schedules other than the currently recommended...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related